160 related articles for article (PubMed ID: 24023917)
1. Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.
Lal G; Contreras PG; Kulak M; Woodfield G; Bair T; Domann FE; Weigel RJ
PLoS One; 2013; 8(9):e73953. PubMed ID: 24023917
[TBL] [Abstract][Full Text] [Related]
2. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.
Spanheimer PM; Woodfield GW; Cyr AR; Kulak MV; White-Baer LS; Bair TB; Weigel RJ
Ann Surg Oncol; 2013 Jul; 20(7):2204-12. PubMed ID: 22878616
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of the mouse Ecm1 gene and its 5' regulatory sequences.
Smits P; Bhalerao J; Merregaert J
Gene; 1999 Jan; 226(2):253-61. PubMed ID: 9931498
[TBL] [Abstract][Full Text] [Related]
5. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
[TBL] [Abstract][Full Text] [Related]
6. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
[TBL] [Abstract][Full Text] [Related]
7. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.
Gómez-Contreras P; Ramiro-Díaz JM; Sierra A; Stipp C; Domann FE; Weigel RJ; Lal G
Clin Exp Metastasis; 2017 Jan; 34(1):37-49. PubMed ID: 27770373
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).
Wong PP; Miranda F; Chan KV; Berlato C; Hurst HC; Scibetta AG
Mol Cell Biol; 2012 May; 32(9):1633-44. PubMed ID: 22371483
[TBL] [Abstract][Full Text] [Related]
11. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
Delacroix L; Begon D; Chatel G; Jackers P; Winkler R
DNA Cell Biol; 2005 Sep; 24(9):582-94. PubMed ID: 16153159
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the promoter of cancer-related gene LOXL2.
Liu X; Liu T; Hu L; Jiang T; Liu H; Wang Y; Lei Y; Zhu J; Bu Y
Exp Cell Res; 2020 Feb; 387(2):111786. PubMed ID: 31870772
[TBL] [Abstract][Full Text] [Related]
13. Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells.
Domenzain-Reyna C; Hernández D; Miquel-Serra L; Docampo MJ; Badenas C; Fabra A; Bassols A
J Biol Chem; 2009 May; 284(18):12306-17. PubMed ID: 19269971
[TBL] [Abstract][Full Text] [Related]
14. Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma.
Tellez C; McCarty M; Ruiz M; Bar-Eli M
J Biol Chem; 2003 Nov; 278(47):46632-42. PubMed ID: 12975361
[TBL] [Abstract][Full Text] [Related]
15. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
Clem AL; Hamid T; Kakar SS
Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
[TBL] [Abstract][Full Text] [Related]
17. Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.
Zhou T; Chiang CM
Nucleic Acids Res; 2002 Oct; 30(19):4145-57. PubMed ID: 12364593
[TBL] [Abstract][Full Text] [Related]
18. TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial-mesenchymal transition.
Kim W; Kim E; Lee S; Kim D; Chun J; Park KH; Youn H; Youn B
Exp Mol Med; 2016 Nov; 48(11):e273. PubMed ID: 27885255
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor AP-2γ induces early Cdx2 expression and represses HIPPO signaling to specify the trophectoderm lineage.
Cao Z; Carey TS; Ganguly A; Wilson CA; Paul S; Knott JG
Development; 2015 May; 142(9):1606-15. PubMed ID: 25858457
[TBL] [Abstract][Full Text] [Related]
20. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
